Institute for Cardiovascular Regeneration, Centre of Molecular Medicine, Goethe University Frankfurt, Theodor Stern Kai 7, 60590 Frankfurt, Germany.
German Center for Cardiovascular Research DZHK, Partner site Frankfurt Rhine-Main, Berlin, Germany.
Eur Heart J. 2022 Nov 14;43(43):4536-4547. doi: 10.1093/eurheartj/ehac095.
Cardiovascular disease remains the leading cause of death worldwide. A deeper understanding of the multicellular composition and molecular processes may help to identify novel therapeutic strategies. Single-cell technologies such as single-cell or single-nuclei RNA sequencing provide expression profiles of individual cells and allow for dissection of heterogeneity in tissue during health and disease. This review will summarize (i) how these novel technologies have become critical for delineating mechanistic drivers of cardiovascular disease, particularly, in humans and (ii) how they might serve as diagnostic tools for risk stratification or individualized therapy. The review will further discuss technical pitfalls and provide an overview of publicly available human and mouse data sets that can be used as a resource for research.
心血管疾病仍然是全球范围内的主要死亡原因。更深入地了解多细胞组成和分子过程可能有助于确定新的治疗策略。单细胞技术,如单细胞或单细胞核 RNA 测序,提供了单个细胞的表达谱,并允许在健康和疾病期间对组织中的异质性进行剖析。这篇综述将总结 (i) 这些新技术如何成为阐明心血管疾病机制驱动因素的关键,特别是在人类中,以及 (ii) 它们如何作为风险分层或个体化治疗的诊断工具。该综述还将进一步讨论技术缺陷,并概述可作为研究资源的公开可用的人类和小鼠数据集。